Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with lung squamous cell carcinoma (a specific type of lung cancer), confirmed by a laboratory test of tissue or cell samples
- People aged between 18 and 75 years old
- People who are willing to take part in the study and sign a consent form
- People whose lung cancer has not yet been treated
- People whose cancer is classified as stage II to stage IIIb and has been assessed by doctors as able to be surgically removed, or potentially able to be surgically removed, based on a standard cancer staging system
- People for whom enough tissue or blood samples are available to meet the study's testing requirements
- People with a performance score of 0 or 1 on the ECOG scale, which means they are either fully active or have only minor limitations in physical activity (confirm with trial site)
Who may not be able to join:
- People who are unable to understand what the trial involves or who are unwilling to sign the consent form
- People whose lung cancer is a non-squamous type
- People whose stage IIIa to IIIb cancer has been assessed as unable to be surgically removed
- People who have previously received a solid organ or bone marrow transplant
- People who have previously been treated with certain immune-based cancer therapies (specifically CTLA-4, PD-1, or PD-L1 inhibitors)
- People who have a condition involving scarring or inflammation of the lung tissue (interstitial lung disease)
- People who currently have an active acute or chronic infection
- People who are pregnant or breastfeeding
- People who are currently taking part in another clinical drug trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 8685296122
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Pathologic completet response (pCR) rate; ctDNA resolution; Development of computer algorithm to identify pCR features; Validation of computer algorithm to identify pCR features
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.